{
    "page": {
        "original_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial intelligence in liver diseases Improving diagnostics, prognostics and response prediction/pages/page_10.png",
        "current_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial intelligence in liver diseases Improving diagnostics, prognostics and response prediction/pages_ordered/page_10.png",
        "image_width": 2481,
        "image_height": 3308,
        "regions_num": 2,
        "page_idx": 10
    },
    "regions": [
        {
            "idx": 1,
            "thing": "list",
            "score": 90.69,
            "box": [
                193.6,
                267.1,
                1223.0,
                3067.4
            ],
            "crop_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial intelligence in liver diseases Improving diagnostics, prognostics and response prediction/crops_ordered/page_10/region_1_list.png",
            "text": "[50] Elsayes KM, Fowler KJ, Chernyak V, Elmohr MM, Kielar AZ, Hecht E, et al.\nUser and system pitfalls in liver imaging with LI-RADS. J Magn Reson\nImaging 2019;50:1673-1686.\n\n[51] Vitale A, Farinati F, Finotti M, Di Renzo C, Brancaccio G, Piscaglia F, et al.\nOverview of prognostic systems for hepatocellular carcinoma and ITA.LI.\nCA external validation of MESH and CNLC classifications. Cancers\n2021;13:1673. https://doi.org/10.3390/cancers13071673.\n\n[52] Beumer BR, Buettner S, Galjart B, van Vugt JLA, de Man RA,\nIJzermans JNM, et al. Systematic review and meta-analysis of\nvalidated prognostic models for resected hepatocellular carcinoma\npatients. Eur J Surg Oncol 2021. https://doi.org/10.1016/j.ejso.2021.09.\n012.\n\n[53] Chapiro J, Geschwind J-F. Have we finally found the ultimate staging\nsystem for HCC? Nat Rev Gastroenterol Hepatol 2014;11:334-336.\n\n[54] Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul J-L, et al.,\nEuropean Association for the Study of the Liver. EASL clinical practice\nguidelines: management of hepatocellular carcinoma. J Hepatol\n2018;69:182-236.\n\n[55] Bruix J, Chan SL, Galle PR, Rimassa L, Sangro B. Systemic treatment of\nhepatocellular carcinoma: an EASL position paper. J Hepatol\n2021;75:960-974.\n\n[56] Masch WR, Kampalath R, Parikh N, Shampain KA, Aslam A, Chernyak V.\nImaging of treatment response during systemic therapy for hepatocel-\nlular carcinoma. Abdom Radiol (NY) 2021;46:3625-3633.\n\n[57] Berzigotti A, Tsochatzis E, Boursier J, Castera L, Cazzagon N, Friedrich-\nRust M, et al. EASL Clinical Practice Guidelines on non-invasive tests for\nevaluation of liver disease severity and prognosis - 2021 update.\nJ Hepatol 2021;75:659-689. https://doi.org/10.1016/j.jhep.2021.05.025.\n\n[58] van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B.\nRadiomics in medical imaging—“how-to” guide and critical reflection.\nInsights Imaging 2020;11:1-16.\n\n[59] Chartrand G, Cheng PM, Vorontsov E, Drozdzal M, Turcotte S, Pal CJ, et al.\nDeep learning: a primer for radiologists. Radiographics 2017;37:2113-\n2131.\n\n[60] Ronneberger O, Fischer P, Brox T. U-net: convolutional networks for\nbiomedical image segmentation. Lecture Notes Comp Sci 2015:234-241.\nhttps://doi.org/10.1007/978-3-319-24574-4_28.\n\n[61] Christ PF, Elshaer MEA, Ettlinger F, Tatavarty S, Bickel M, Bilic P, et al.\nAutomatic liver and lesion segmentation in CT using cascaded fully\nconvolutional neural networks and 3D conditional random fields. In:\nMedical Image Computing and Computer-Assisted Intervention -\nMICCAI 2016. Springer International Publishing; 2016. p. 415-423.\n\n[62] Sun C, Guo S, Zhang H, Li J, Chen M, MaS, et al. Automatic segmentation\nof liver tumors from multiphase contrast-enhanced CT images based on\nFCNs. Artif Intell Med 2017;83:58-66.\n\n[63] Bilic P, Christ PF, Vorontsov E, Chlebus G, Chen H, Dou Q, et al. The Liver\nTumor Segmentation Benchmark (LiTS). arXiv [csCV]. 2019.\n\n[64] Li X, Chen H, Qi X, Dou Q, Fu C-W, Heng P-A. H-DenseUNet: Hybrid\ndensely connected UNet for liver and tumor segmentation from CT\nvolumes. IEEE Trans Med Imaging 2018;37:2663-2674.\n\n[65] Bousabarah K, Letzen B, Tefera J, Savic L, Schobert I, Schlachter T, et al.\nAutomated detection and delineation of hepatocellular carcinoma on\nmultiphasic contrast-enhanced MRI using deep learning. Abdom Radiol\n(NY) 2021;46:216-225.\n\n[66] He K, Liu X, Shahzad R, Reimer R, Thiele F, Niehoff J, et al. Advanced deep\nlearning approach to automatically segment malignant tumors and\nablation zone in the liver with contrast-enhanced CT. Front Oncol\n2021;11:669437.\n\n[67] Zhou B, Augenfeld Z, Chapiro J, Zhou SK, Liu C, Duncan JS. Anatomy-\nguided multimodal registration by learning segmentation without\nground truth: application to intraprocedural CBCT/MR liver segmenta-\ntion and registration. Med Image Anal 2021;71:102041.\n\n[68] Biswas M, Kuppili V, Edla DR, Suri HS, Saba L, Marinhoe RT, et al. Sym-\ntosis: a liver ultrasound tissue characterization and risk stratification in\noptimized deep learning paradigm. Comput Methods Programs Biomed\n2018;155:165-177.\n\n[69] Byra M, Styczynski G, Szmigielski C, Kalinowski P, Michalowski tL,\nPaluszkiewicz R, et al. Transfer learning with deep convolutional neural\nnetwork for liver steatosis assessment in ultrasound images. Int J\nComput Assist Radiol Surg 2018;13:1895-1903.\n\n[70] Graffy PM, Sandfort V, Summers RM, Pickhardt PJ. Automated liver fat\nquantification at nonenhanced abdominal CT for population-based\nsteatosis assessment. Radiology 2019;293:334-342.\n\n[71] Han A, Byra M, Heba E, Andre MP, Erdman Jr JW, Loomba R, et al.\nNoninvasive diagnosis of nonalcoholic fatty liver disease and\n"
        },
        {
            "idx": 2,
            "thing": "list",
            "score": 91.78,
            "box": [
                1281.2,
                265.8,
                2307.3,
                2994.8
            ],
            "crop_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial intelligence in liver diseases Improving diagnostics, prognostics and response prediction/crops_ordered/page_10/region_2_list.png",
            "text": "quantification of liver fat with radiofrequency ultrasound data using\none-dimensional convolutional neural networks. Radiology\n2020;295:342-350.\n\n[72] Wang K, Lu X, Zhou H, Gao Y, Zheng J, Tong M, et al. Deep learning\nRadiomics of shear wave elastography significantly improved diagnostic\nperformance for assessing liver fibrosis in chronic hepatitis B: a pro-\nspective multicentre study. Gut 2019;68:729-741.\n\n[73] Choi KJ, Jang JK, Lee SS, Sung YS, Shim WH, Kim HS, et al. Development\nand validation of a deep learning system for staging liver fibrosis by\nusing contrast agent-enhanced CT images in the liver. Radiology\n2018;289:688-697.\n\n[74] Yasaka K, Akai H, Kunimatsu A, Abe O, Kiryu S. Liver fibrosis: deep\nconvolutional neural network for staging by using gadoxetic acid-\nenhanced hepatobiliary phase MR images. Radiology 2018;287:146-155.\n\n[75] Yasaka K, Akai H, Abe O, Kiryu S. Deep learning with convolutional\nneural network for differentiation of liver masses at dynamic contrast-\nenhanced CT: a preliminary study. Radiology 2018;286:887-896.\n\n[76] Hamm CA, Wang CJ, Savic LJ, Ferrante M, Schobert I, Schlachter T, et al.\nDeep learning for liver tumor diagnosis part I: development of a con-\nvolutional neural network classifier for multi-phasic MRI. Eur Radiol\n2019;29:3338-3347.\n\n[77] Oestmann PM, Wang CJ, Savic LJ, Hamm CA, Stark S, Schobert I, et al.\nDeep learning-assisted differentiation of pathologically proven atypical\nand typical hepatocellular carcinoma (HCC) versus non-HCC on\ncontrast-enhanced MRI of the liver. Eur Radiol 2021;31:4981-4990.\n\n[78] Peng J, Zhang J, Zhang Q, Xu Y, Zhou J, Liu L. A radiomics nomogram for\npreoperative prediction of microvascular invasion risk in hepatitis B\nvirus-related hepatocellular carcinoma. Diagn Interv Radiol\n2018;24:121-127.\n\n[79] Ma X, Wei J, Gu D, Zhu Y, Feng B, Liang M, et al. Preoperative radiomics\nnomogram for microvascular invasion prediction in hepatocellular car-\ncinoma using contrast-enhanced CT. Eur Radiol 2019;29:3595-3605.\n\n[80] Xu X, Zhang H-L, Liu Q-P, Sun S-W, Zhang J, Zhu F-P, et al. Radiomic\nanalysis of contrast-enhanced CT predicts microvascular invasion and\noutcome in hepatocellular carcinoma. J Hepatol 2019;70:1133-1144.\n\n[81] Feng S-T, Jia Y, Liao B, Huang B, Zhou Q, Li X, et al. Preoperative pre-\ndiction of microvascular invasion in hepatocellular cancer: a radiomics\nmodel using Gd-EOB-DTPA-enhanced MRI. Eur Radiol 2019;29:4648-\n4659.\n\n[82] Jiang Y-Q, Cao S-E, Cao S, Chen J-N, Wang G-Y, Shi W-Q, et al. Preoper-\native identification of microvascular invasion in hepatocellular carci-\nnoma by XGBoost and deep learning. J Cancer Res Clin Oncol\n2021;147:821-833.\n\n[83] Song D, Wang Y, Wang W, Wang Y, Cai J, Zhu K, et al. Using deep learning\nto predict microvascular invasion in hepatocellular carcinoma based on\ndynamic contrast-enhanced MRI combined with clinical parameters.\nJ Cancer Res Clin Oncol 2021. https://doi.org/10.1007/s00432-021-\n03617-3.\n\n[84] Zhou W, Jian W, Cen X, Zhang L, Guo H, Liu Z, et al. Prediction of\nmicrovascular invasion of hepatocellular carcinoma based on contrast-\nenhanced MR and 3D convolutional neural networks. Front Oncol\n2021;11:588010.\n\n[85] Abajian A, Murali N, Savic LJ, Laage-Gaupp FM, Nezami N, Duncan JS,\net al. Predicting treatment response to intra-arterial therapies for he-\npatocellular carcinoma with the use of supervised machine learning-an\nartificial intelligence concept. J Vasc Interv Radiol 2018;29:850-857.e1.\n\n[86] Morshid A, Elsayes KM, Khalaf AM, Elmohr MM, Yu J, Kaseb AO, et al.\nA machine learning model to predict hepatocellular carcinoma response\nto transcatheter arterial chemoembolization. Radiol Artif Intell 2019;1.\nhttps://doi.org/10.1148/ryai.2019180021.\n\n[87] Peng J, Kang S, Ning Z, Deng H, Shen J, Xu Y, et al. Residual convolutional\nneural network for predicting response of transarterial chemo-\nembolization in hepatocellular carcinoma from CT imaging. Eur Radiol\n2020;30:413-424.\n\n[88] Jin Z, Chen L, Zhong B, Zhou H, Zhu H, Zhou H, et al. Machine-learning\nanalysis of contrast-enhanced computed tomography radiomics predicts\npatients with hepatocellular carcinoma who are unsuitable for initial\ntransarterial chemoembolization monotherapy: a multicenter study.\nTransl Oncol 2021;14:101034.\n\n[89] Hu H-T, Shan Q-Y, Chen S-L, Li B, Feng S-T, Xu E-J, et al. CT-based\nradiomics for preoperative prediction of early recurrent hepatocellular\ncarcinoma: technical reproducibility of acquisition and scanners. Radiol\nMed 2020;125:697-705.\n"
        }
    ]
}